Latest News

Whole Gland Cryoablation Resulted in “Excellent” Outcomes in Localized Prostate Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

A team of investigators reported outcomes associated with the use of whole gland cryoablation among men with localized prostate cancer.

KRAS and PI3K Pathway Alterations Affect Survival in Patients With Pancreatic Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

A team of investigators identified prognostic genomic markers among patients with metastatic or locally advanced pancreatic ductal adenocarcinoma.

More Than Half of Oncologists Willing to Reduce Initial Dose in Metastatic Setting

By

Leah Lawrence

Survey results reveal whether oncologists are willing to adjust initial drug doses for some patients with metastatic cancer.

Local Docetaxel Therapy May Benefit Patients With High-Risk NMIBC

By

Natasha Persaud

Of 19 patients with high-risk NMIBC treated with local docetaxel, 14 had prior BCG exposure.

Radiographers Read Mammograms for UK Double Reading Program

Cancer detection rate, recall rate, and positive predictive value were similar for radiologists and trained radiographers as first readers.

Early Natural Menopause Is a Risk Factor for Lung Diseases in Women Who Smoke

By

Ron Goldberg

How does early natural menopause affect lung health, aging, and mortality in women who smoke?

NCCN Updates Recommendations for COVID-19 Vaccination

By

Leah Lawrence

NCCN has updated its recommendations on COVID-19 vaccination to include advice about bivalent vaccines, vaccinating immunocompromised children, and more.

Adding Ifosfamide to MAP Provides No Benefit in High-Grade Osteosarcoma

By

Leah Lawrence

Phase 3 data do not support adding ifosfamide to adjuvant methotrexate, doxorubicin, and cisplatin in patients with high-grade osteosarcoma.

Adjuvant Pembrolizumab Prolongs DFS in Resected Non-Small Cell Lung Cancer

By

Andrea S. Blevins Primeau, PhD, MBA

Pembrolizumab is a potential new treatment option for stage IB-IIIA non-small cell lung cancer after complete resection, according to researchers.

T1a RCC Death Risk Higher After Ablation vs Partial Nephrectomy

By

Natasha Persaud

The study included a large, contemporary cohort of patients with T1a renal cell carcinoma undergoing partial nephrectomy or local tumor destruction.

Venetoclax Plus Azacitidine Appears Promising in High-Risk MDS, CMML

By

Jonathan Goodman, MPhil

Researchers sought to determine whether azacitidine plus venetoclax would be effective in patients with high-risk MDS or chronic myelomonocytic leukemia.

Self-Reported Lung-Related Comorbidities Do Not Impact Lung Cancer Screening Outcomes

By

Jessica Nye, PhD

Researchers sought to determine if self-reported lung-related comorbidities are an indicator of poor outcomes on lung cancer screening.

Bivalent mRNA-1273.214 Elicits Better Response Against Omicron

mRNA-1273.214 elicits more neutralizing antibodies against omicron subvariants than does mRNA-1273.

Many Patients With Advanced NSCLC Do Not Survive Beyond First-Line Therapy

By

Andrea S. Blevins Primeau, PhD, MBA

Many patients with advanced non-small cell lung cancer do not survive long enough to receive second-line therapy, a real-world study suggests.

SBRT Does Not Improve Efficacy of Nivo-Ipi in Advanced Merkel Cell Carcinoma

By

Leah Lawrence

SBRT did not improve the efficacy of nivolumab-ipilimumab in patients with advanced Merkel cell carcinoma in a phase 2 study.

Odds of Fair/Poor Health Up for Low-Income Cancer Survivors

Low-income cancer survivors have increased odds of not being able to see a doctor and reduced odds of having health insurance coverage.

Improving the Rate of Serious Illness Conversations at Oncology Clinics

By

Vicki Moore, PhD

Researchers sought to increase the rate of serious illness conversations between clinicians and patients with cancer.

Tisagenlecleucel Plus Pembrolizumab May Be Effective in R/R DLBCL

By

Lauren Dembeck, PhD

Tisagenlecleucel plus pembrolizumab produced responses in patients with relapsed/refractory diffuse large B-cell lymphoma.

FDA Clears SKOUT to Detect Colorectal Polyps in Real Time During Colonoscopy

By

Brian Park, PharmD

SKOUT is designed to recognize suspicious tissue and provide real-time feedback.

Chemo Does Not Improve Long-Term Outcomes in Early-Stage ILC

By

Andrea S. Blevins Primeau, PhD, MBA

Chemotherapy does not improve long-term outcomes in patients with early-stage invasive lobular carcinoma, according to a meta-analysis.